MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹335 Cr | ₹18 Cr | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr |
What is the latest Contingent Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹335 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹9.76 Cr |
| Mar2023 | ₹6.66 Cr |
| Mar2022 | ₹2.64 Cr |
How is Contingent Liabilities of MOREPEN LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹335 Cr | 1,730.99 | |
| Mar2025 | ₹18 Cr | 87.61 | |
| Mar2024 | ₹9.76 Cr | 46.52 | |
| Mar2023 | ₹6.66 Cr | 152.33 | |
| Mar2022 | ₹2.64 Cr | - | |
Compare Contingent Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,466.3 Cr | 5.7% | -22% | 104.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 5.7% |
-22% |
104.2% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses